<SEC-DOCUMENT>0001193125-23-210772-index.html : 20230811 <SEC-HEADER>0001193125-23-210772.hdr.sgml : 20230811 <ACCEPTANCE-DATETIME>20230811161855 ACCESSION NUMBER: 0001193125-23-210772 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 GROUP MEMBERS: EMILY FAIRBAIRN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-92777 FILM NUMBER: 231164405 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Transcend Partners Opportunity Fund I LLC CENTRAL INDEX KEY: 0001832019 IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 10 ORINDA VIEW ROAD CITY: ORINDA STATE: CA ZIP: 94563 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: 10 ORINDA VIEW ROAD CITY: ORINDA STATE: CA ZIP: 94563 FORMER COMPANY: FORMER CONFORMED NAME: Transcend Partners Opportunity Fund LLC DATE OF NAME CHANGE: 20201112 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>d514664dsc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: d514664dsc13g.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>d514664dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: d514664dex991.htm
</DOCUMENT> </SEC-DOCUMENT>